Anatomy of an Oxford Startup
We are delighted to invite you to our next event in the Nucleate Identify Series: Anatomy of an Oxford Startup.
This event will be open to all and offer a unique opportunity to gain insights into the journeys of building a biotech startup at the University of Oxford. Through discussions with top founders and networking opportunities, we will explore the challenges and opportunities of biotech venture creation in the Oxford and wider UK ecosystem.
Event Highlights:
Panel Discussion:
David Kim (Co-founder and CEO - Cyanocapture)
Ross Hendron (Co-founder and CEO - Wild Bioscience)
Danuta Jeziorska (Co-founder and former-CEO - Nucleome Therapeutics)
Keynote Conversation:
A fireside chat with Tim Funnell, partner and co-founder of Monograph Capital. Prior to Monograph, Tim was an operational co-founder of Oxford spin-out MiroBio which was acquired by Gilead in 2022.
This event is a must-attend for early-career researchers, investors, and stakeholders eager to understand the landscape of biotech innovation and venture building in Oxford.
Event schedule:
Registration: 6-6:45pm
Panel: 6:45-7.15pm
Fireside chat: 7.30-8pm
Networking Reception: 8-9.30pm
Nucleate Identify is powered through our partnership with the Advanced Research + Invention Agency (ARIA).